Neoplasms Metastasis Recruiting Phase 3 Trials for Tanezumab (DB12335)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Recruiting3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02609828Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy.Treatment